Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $16.6750 (4.35%) ($16.6750 - $16.6750) on Mon. Jun. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.03% (three month average) | RSI | 58 | Latest Price | $16.6750(4.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(38%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.515% in a week (0% probabilities). VIXM(-23%) UUP(-14%) VXX(-7%) IGOV(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.515% (StdDev 5.03%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $16.17(3.12%) | 10 Day Moving Average | $16.48(1.18%) | 20 Day Moving Average | $15.96(4.48%) | To recent high | -3.2% | To recent low | 75.6% | Market Cap | $2.942b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |